During the past decade, Hospital Nuestra Señora de Sonsoles conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nuestra Señora de Sonsoles" #1 sponsor was "PETHEMA Foundation" with 9 trials, followed by "Spanish Breast Cancer Research Group" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Spanish Lung Cancer Group" with 2 trials sponsored and "ALK-Abelló A/S" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nuestra Señora de Sonsoles" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Cellestia Biotech AG" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nuestra Señora de Sonsoles" are "Acute Lymphoblastic Leukemia" (3 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Lung Cancer" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Hospital Nuestra Señora de Sonsoles" in a lesser frequency.

Most popular intervention types in "Hospital Nuestra Señora de Sonsoles" are "Drug" (27 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cyclophosphamide" (3 trials), "Cytarabine" (3 trials), "Prednisone" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nuestra Señora de Sonsoles" are 27 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Nuestra Señora de Sonsoles". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Hospital Nuestra Señora de Sonsoles, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nuestra Señora de Sonsoles, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".